AdaptHealth (AHCO)
(Delayed Data from NSDQ)
$10.06 USD
+0.21 (2.13%)
Updated May 1, 2024 04:00 PM ET
After-Market: $10.06 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
A Value A Growth D Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
AHCO 10.06 +0.21(2.13%)
Will AHCO be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for AHCO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AHCO
Philips (PHG) Q1 Earnings Beat Estimates, Revenues Fall Y/Y
AHCO vs. BSX: Which Stock Is the Better Value Option?
AHCO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is AdaptHealth (AHCO) Stock Outpacing Its Medical Peers This Year?
AHCO or BSX: Which Is the Better Value Stock Right Now?
Philips (PHG) Boosts Patient Monitoring With smartQare Deal
Other News for AHCO
Analysts Have Conflicting Sentiments on These Healthcare Companies: Inspire Medical Systems (INSP) and AdaptHealth (AHCO)
Wall Street Analysts Are Bullish on Top Healthcare Picks
AdaptHealth Corp. Announces First Quarter 2024 Earnings Release Date and Conference Call
AdaptHealth Appoints Suzanne Foster as Chief Executive Officer
AHCO Makes Notable Cross Below Critical Moving Average